Course will allow delegates to develop the knowledge needed to successfully navigate the pharmaceutical market in China.
With growth and innovation faltering in other markets, failure in China is not an option – the diabetes market alone has been predicted to swell to $2.1 billion by 2019.
Using a combination of theory and practical case studies, the course will allow delegates to develop the knowledge needed to successfully navigate the pharmaceutical market in China. The commercial significance of the Chinese market is increasing – however there are still many barriers to drug registration, which currently takes around 2½ years on average. It is crucial that pharmaceutical companies keep up-to-date with the latest regulatory developments to ensure their slice of the ballooning market.
This essential 2-day course will provide you with the latest updates on the regulatory processes for gaining marketing authorisation in China including registration procedures, timelines and communication with authorities.
+44 (0) 20 7017 7481